---
title: "ESPR.US (ESPR.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ESPR.US/news.md"
symbol: "ESPR.US"
name: "ESPR.US"
parent: "https://longbridge.com/en/quote/ESPR.US.md"
datetime: "2026-06-13T14:56:28.961Z"
locales:
  - [en](https://longbridge.com/en/quote/ESPR.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ESPR.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ESPR.US/news.md)
---

# ESPR.US (ESPR.US) — Related News

### [Esperion cleared for merger by German antitrust authority; stockholder vote set for July 8](https://longbridge.com/en/news/289231651.md)
*2026-06-09T20:03:01.000Z*
> Esperion Therapeutics received clearance from the German Bundeskartellamt for its merger with Essence Parent Inc. The co

### [Esperion Therapeutics’ 10-Q Forward-Looking Statements Highlight Significant Uncertainty and Investor Risk](https://longbridge.com/en/news/285830726.md)
*2026-05-10T06:02:15.000Z*
> Esperion Therapeutics (ESPR) has highlighted significant uncertainty in its 10-Q filing, emphasizing that forward-lookin

### [Key facts: Esperion Expands 2024–25 Programs; Estimates Fall 781.6%](https://longbridge.com/en/news/285820903.md)
*2026-05-09T20:03:01.000Z*
> Esperion (ESPR) advanced clinical programs in 2024–2025, including a pediatric trial, and secured expanded indications a

### [14:27 ETSHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESPR, SILA, CRBG, and EQH](https://longbridge.com/en/news/285420856.md)
*2026-05-06T18:27:21.000Z*
> Class Action Attorney Juan Monteverde of Monteverde & Associates PC is investigating mergers involving Esperion Therapeu

### [Esperion (ESPR) was downgraded to a Hold Rating at Needham](https://longbridge.com/en/news/285108916.md)
*2026-05-04T19:05:35.000Z*
> Esperion (ESPR) has been downgraded to a Hold rating by Needham analyst Serge Belanger, who set a price target of $3.22.

### [14:53 ETAre ESPR, GBTG, MDV, ACR Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/285107847.md)
*2026-05-04T18:53:59.000Z*
> Halper Sadeh LLC is investigating potential violations of federal securities laws by Esperion Therapeutics, Global Busin

### [Esperion Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Esperion Therapeutics, Inc. - ESPR](https://longbridge.com/en/news/285095483.md)
*2026-05-04T16:00:50.000Z*
> Kahn Swick & Foti, LLC is investigating the proposed sale of Esperion Therapeutics, Inc. (NasdaqGM: ESPR) to ARCHIMED fu

### [What's Going On With Esperion Therapeutics Stock On Monday?](https://longbridge.com/en/news/285093535.md)
*2026-05-04T15:25:05.000Z*
> Esperion Therapeutics shares rose on Monday following a $1.1 billion buyout deal with Archimed, offering shareholders $3

### [Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more](https://longbridge.com/en/news/284999219.md)
*2026-05-03T15:27:21.000Z*
> Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more